RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Donald Kurtz to Blood Substitutes

This is a "connection" page, showing publications Donald Kurtz has written about Blood Substitutes.
Connection Strength

0.828
  1. Arkosi M, Scurtu F, Vulpoi A, Silaghi-Dumitrescu R, Kurtz D. Copolymerization of recombinant Phascolopsis gouldii hemerythrin with human serum albumin for use in blood substitutes. Artif Cells Nanomed Biotechnol. 2017 Mar; 45(2):218-223.
    View in: PubMed
    Score: 0.606
  2. Hathazi D, Mot AC, Vaida A, Scurtu F, Lupan I, Fischer-Fodor E, Damian G, Kurtz DM, Silaghi-Dumitrescu R. Oxidative protection of hemoglobin and hemerythrin by cross-linking with a nonheme iron peroxidase: potentially improved oxygen carriers for use in blood substitutes. Biomacromolecules. 2014 May 12; 15(5):1920-7.
    View in: PubMed
    Score: 0.126
  3. Mot AC, Roman A, Lupan I, Kurtz DM, Silaghi-Dumitrescu R. Towards the development of hemerythrin-based blood substitutes. Protein J. 2010 Aug; 29(6):387-93.
    View in: PubMed
    Score: 0.097
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support